Modular Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Modular Medical (MODD).

Price Target Range — 1 Quarters

Analyst Consensus

Consensus RatingSpeculative BuyAvg. Consensus PT$150Upside to Avg. PT+7836.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Mar 21, 2024	Benchmark	Bruce Jackson	Maintained	Speculative Buy	$150

Analyst Ratings News

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

Benchmark analyst Bruce Jackson reiterates Modular Medical (NASDAQ:MODD) with a Speculative Buy and maintains $5 price target.

Benzinga Newsdesk

PRO
Oppenheimer Reiterates Outperform on Modular Medical, Maintains $3.5 Price Target

Oppenheimer analyst Steven Lichtman reiterates Modular Medical (NASDAQ:MODD) with a Outperform and maintains $3.5 price target.

Benzinga Newsdesk

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

Benchmark analyst Bruce Jackson reiterates Modular Medical (NASDAQ:MODD) with a Speculative Buy and maintains $5 price target.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Modular Medical, Lowers Price Target to $3.5

Oppenheimer analyst Steven Lichtman maintains Modular Medical (NASDAQ:MODD) with a Outperform and lowers the price target from $6 to $3.5.

Benzinga Newsdesk

PRO
Benchmark Maintains Speculative Buy on Modular Medical, Lowers Price Target to $5

Benchmark analyst Bruce Jackson maintains Modular Medical (NASDAQ:MODD) with a Speculative Buy and lowers the price target from $8 to $5.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2022

Upgrades

Benzinga Insights

Modular Medical Inc

Modular Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PRO
Oppenheimer Reiterates Outperform on Modular Medical, Maintains $3.5 Price Target

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PRO
Oppenheimer Maintains Outperform on Modular Medical, Lowers Price Target to $3.5

PRO
Benchmark Maintains Speculative Buy on Modular Medical, Lowers Price Target to $5

Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2022

People Also Watch

People Also Watch

Modular Medical Inc

Modular Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROBenchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PROOppenheimer Reiterates Outperform on Modular Medical, Maintains $3.5 Price Target

PROBenchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PROOppenheimer Maintains Outperform on Modular Medical, Lowers Price Target to $3.5

PROBenchmark Maintains Speculative Buy on Modular Medical, Lowers Price Target to $5

Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2022

People Also Watch

People Also Watch

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PRO
Oppenheimer Reiterates Outperform on Modular Medical, Maintains $3.5 Price Target

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PRO
Oppenheimer Maintains Outperform on Modular Medical, Lowers Price Target to $3.5

PRO
Benchmark Maintains Speculative Buy on Modular Medical, Lowers Price Target to $5